Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females

Gut

Volumn 58, Issue 1, 2009, Pages 16-23

  Derakhshan, M H ^a   Liptrot, S ^a   Paul, J ^a   Brown, L ^a   Morrison, D ^b   McColl, K E L ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b SCOTTISH UNIVERSITIES ENVIRONMENTAL RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER LOCALIZATION; CARDIA; CARDIA CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HUMAN; INTESTINE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; STOMACH ADENOCARCINOMA; TUMOR BIOPSY; UNITED KINGDOM; ADENOCARCINOMA; EPIDEMIOLOGY; ESOPHAGUS TUMOR; MIDDLE AGED; PATHOLOGY; SEX RATIO; STOMACH TUMOR; TIME;

ADENOCARCINOMA; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC METHODS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; SCOTLAND; SEX DISTRIBUTION; STOMACH NEOPLASMS; TIME FACTORS;

EID: 58249085433     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.161331     Document Type: Article

References (51)

1. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64:31-49.
2. Coma P, Haenszel W, Cuello C, et al. A model for gastric cancer epidemiology. Lancet 1975; 2:58-60.
3. Endo S, Ohkusa T, Sarto Y, et al. Detection of Helicobacter pylori infection in early stage gastric cancer. A comparison between intestinal- and diffuse-type gastric adenocarcinomas. Cancer 1995; 75:2203-8.
4. Wu MS, Yang KC, Shun CT, et al. Distinct clinicopathologic characteristics of diffuseand intestinal-type gastric cancer in Taiwan. J Clin Gastroenterol 1997; 25:646-9.
5. Lynch HT, Grady W, Suriano G, et al. Gastric cancer: new genetic developments. J Surg Oncol 2005; 90:114-33; discussion 133.
6. Sippenan P, Kekki M, Siurala M. Increased risk of gastric cancer in males affects the intestinal type of cancer and is independent of age, location of the tumour and atrophic gastritis. Br J Cancer 1988; 57:332-6.
7. Sharaia P, Sampliner RE. The rising incidence of esophageal adenocarcinoma. Adv Intern Med 2001; 46:137-53.
8. Wu X, Chen VW, Ruiz B, et al. Incidence of esophageal and gastric carcinomas among American Asians/Pacific Islanders, whites, and blacks: subsite and histology differences. Cancer 2006; 106:683-92.
9. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340:825-31.
10. Dvorak K, Payne CM, Chavarria M, et al. Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus. Gut 2007; 56:763-71.
11. Radigan LR, Glover JL, Shipley FE, et al. Barrett esophagus. Arch Surg 1977; 112:486-91.
12. Hamilton SR, Smith RR, Cameron JL. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol 1988; 19:942-8.
13. Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents, Vol VIII. IARC Scientific Publications No. 15. Lyon: International Association for Research on Cancer, 2002.
14. Scottish Cancer Registry, ISD. Cancer stats. http://www. isdscotland.org (accessed 5 April 2006).
15. Brewster DH, Stockton D, Harvey J, et al. Reliability of cancer registration data in Scotland, 1997. Eur J Cancer 2002; 38:414-7.
16. Scottish Cancer Registry, ISD. Cancer Stats. http://www. isdscotland.org/isd/5671 (accessed 15 August 2008).
17. Walsh S, Diamond D. Non-linear curve fitting using Microsoft Excel solver. Talanta 1995; 42:561-72.
18. Kocher HM, Linklater K, Patel S, et al. Epidemiological study of oesophageal and gastric cancer in south-east England. Br J Surg 2001; 88:1249-57.
19. Byrne JP, Mathers JM, Parry JM, et al. Site distribution of oesophagogastric cancer. J Clin Pathol 2002; 55:191-4.
20. Ekstrom AM, Hansson LE, Signorello LB, et al. Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma - a population-based study in Sweden. Br J Cancer 2000; 83:391-6.
21. Hansen S, Vollset SE, Derakhshan MH, et al. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut 2007; 56:918-25.
22. Derakhshan MH, Malekzadeh R, Watabe H, et al. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut 2008; 57:298-305.
23. Correa P, Chen VW. Gastric cancer. Cancer Surv 1994; 19-20:55-76.
24. Sharma P, Sampliner RE. Barrett esophagus. Curr Opin Gastroenterol 2002; 18:471-8.
25. Campos GM, DeMeester SR, Peters JH, et al. Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease. Arch Surg 2001; 136:1267-73.
26. Sipponen P, Correa P. Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer 2002; 5:213-9.
27. van Blankenstein M, Looman CW, Johnston BJ, et al. Age and sex distribution of the prevalence of Barrett's esophagus found in a primary referral endoscopy center. Am J Gastroenterol 2005; 100:568-76.
28. van Soest EM, Siersema PD, Dieleman JP, et al. Age and sex distribution of the incidence of Barrett's esophagus found in a Dutch primary care population. Am J Gastroenterol 2005; 100:2599-600.
29. Hamilton JP, Meltzer SJ. A review of the genomics of gastric cancer. Clin Gastroenterol Hepatol 2006; 4:416-25.
30. Alberg AJ, Ford JG, Samet JM, et al. Epidemiology of lung cancer: ACCP evidencebased clinical practice guidelines. Chest 2007; 132(3 Suppl):29S-55S.
31. Alberg AJ, Kouzis A, Genkinger JM, et al. A prospective cohort study of bladder cancer risk in relation to active cigarette smoking and household exposure to secondhand cigarette smoke. Am J Epidemiol 2007; 165:660-6.
32. Fox JG, Rogers AB, lhrig M, et al. Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res 2003; 63:942-50.
33. Ohtani M, Ge Z, Garcia A, et al. Female hormones provide a protective effect in helicobacter pylori induced gastric disease in INS-GAS mice. Gastroenterology 2006; 130(Suppl 2):A9-10.
34. Ohtani M, Garcia A, Rogers AB, et al. Protective role of 17 beta-estradiol against the development of Helicobacter pylori-induced gastric cancer in INS-GAS mice. Carcinogenesis 2007; 28:2597-604.
35. Palli D, Cipriani F, Decarii A, et al. Reproductive history and gastric cancer among post-menopausal women. Int J Cancer 1994; 56:812-5.
36. Frise S, Kreiger N, Gallinger S, et al. Menstrual and reproductive risk factors and risk for gastric adenocarcinoma in women: findings from the Canadian national enhanced cancer surveillance system. Ann Epidemiol 2006; 16:908-16.
37. Lindblad M, Garcia Rodriguez LA, Chandanos E, et al. Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. Br J Cancer 2006; 94:136-41.
38. Naugler WE, Sakurai T, Kim S, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007; 317:121-4.
39. Harnish DC. Estrogen receptor ligands in the control of pathogenic inflammation. Curr Opin Investig Drugs 2006; 7:997-1001.
40. Huang X. Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. Mutat Res 2003; 533:153-71.
41. Mainous AG 3rd, Wells BJ, Koopman RJ, et al. Iron, lipids, and risk of cancer in the Framingham Offspring cohort. Am J Epidemiol 2005; 161:1115-22.
42. Lee DH, Anderson KE, Folsom AR, et al. Heme iron, zinc and upper digestive tract cancer: the lowa Women's Health Study. Int J Cancer 2005; 117:643-7.
43. Mainous AG 3rd, Gill JM, Everett CJ. Transferrin saturation, dietary iron intake, and risk of cancer. Ann Earn Med 2005; 3:131-7.
44. Chao A, Thun MJ, Henley SJ, et al. Cigarette smoking, use of other tobacco products and stomach cancer mortality in US adults: The Cancer Prevention Study II. Int J Cancer 2002; 101:380-9.
45. Ladeiras-Lopes R, Pereira AK, Nogueira A, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control 2008; 19:689-701.
46. Furukawa H, Iwanaga T, Koyama H, et al. Effect of sex hormones on carcinogenesis in the stomachs of rats. Cancer Res 1982; 42:5181-2.
47. Office of National Statistics. Smoking. In: Living in Britain 1998. results from the General Household Survey. Office of National Statistics; 1998 General Household Survey. Distributed by the Economic and Social Data Service. Edinburgh: HMSO.
48. You WC, Blot WJ, Li JY, et al. Precancerous gastric lesions in a population at high risk of stomach cancer. Cancer Res 1993; 53:1317-21.
49. Watabe H, Yamaji Y, Okamoto M, et al. Gender difference in gastric cancer is unrelated to gastric atrophy. Gut 2007; 56(Suppl 2):A30.
50. Derakhshan MH, Malekzadeh R, Fyfe V, et al. Influence of gender on precancerous changes leading to intestinal type upper gastrointestinal cancer. Gastroenterology 2006; 130(4, Suppl 2):A420.
51. Cook MB, Wild CP, Forman D. A systematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and non erosive reflux disease. Am J Epidemiol 2005; 162:1050-61.